Author Question: The nurse is providing patient education for a group of nurses on the topic of chronic renal failure ... (Read 131 times)

asmith134 · **on:** Jul 23, 2018

The nurse is providing patient education for a group of nurses on the topic of chronic renal failure (CRF).

To evaluate the group's understanding, the nurse asks, What is the greatest benefit of treatment with epoetin alfa in patients in renal failure? The best response would be that the drug
a. replaces erythropoietin no longer produced in the proximal tubules of the kidney because of CRF.
b. neutralizes the kidneys' waste products, which destroy circulating RBCs.
c. metabolizes the hormone that interferes with RBC production.
d. increases the kidneys' excretion of substances that interfere with RBC production.

Question 2

The patient with which of the following is most at risk for folic acid deficiency?

a. Alcoholism
b. Sprue
c. Gastrectomy
d. Peptic ulcer disease

bulacsom · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

ANS: A
Erythropoietin is produced by peritubular cells in the proximal tubules of the kidney. Epoetin alfa replaces erythropoietin that is no longer produced because of CRF.
Epoetin alfa does not neutralize the kidneys' waste products.
Epoetin alfa does not metabolize the hormone that interferes with RBC production.
Epoetin alfa does not increase the kidneys' excretion of substances that interfere with RBC production.

Answer to Question 2

ANS: A
The patient most at risk for folic acid deficiency secondary to a poor diet is a patient with a history of alcoholism.
Malabsorption secondary to intestinal disease is another indication for folic acid therapy, but these patients are not most at risk.